AxoGen, Inc.
AXGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 17.8% | 14.7% | 8.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 75.8% | 76.6% | 78.5% | 82% |
| EBITDA | $0 | -$0 | -$0 | -$0 |
| % Margin | 3.2% | -8.4% | -16.9% | -16.4% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -5.3% | -13.7% | -20.9% | -21.2% |
| EPS Diluted | -0.23 | -0.51 | -0.69 | -0.65 |
| % Growth | 54.9% | 26.1% | -6.2% | – |
| Operating Cash Flow | $0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | -$0 | -$0 | -$0 |